These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 30901062)

  • 21. Elimination of leprosy in India: An analysis.
    Sengupta U
    Indian J Dermatol Venereol Leprol; 2018; 84(2):131-136. PubMed ID: 29451189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hansen's disease: case report and review of literature].
    Concha R M; Cossio T ML; Salazar S I; Fich S F; Pérez C C; González B S
    Rev Chilena Infectol; 2008 Feb; 25(1):64-9. PubMed ID: 18273528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends and patterns of leprosy over a decade in a tertiary care hospital in Northern India: A retrospective analysis.
    Mushtaq S; Dogra N; Dogra D; Faizi N
    Indian J Dermatol Venereol Leprol; 2020; 86(2):141-149. PubMed ID: 31736465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Eradication of leprosy and public health. Vaccination and multidrug therapy].
    Janaszek W
    Przegl Epidemiol; 2002; 56(4):577-86. PubMed ID: 12666583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relapses in multibacillary leprosy patients: a retrospective cohort of 11 years in Colombia.
    Guerrero-Guerrero MI; Muvdi-Arenas S; León-Franco CI
    Lepr Rev; 2012 Sep; 83(3):247-60. PubMed ID: 23356026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Leprosy in French Guyana: a retrospective study from 1997 to 2006].
    Domergue V; Clyti E; Sainte-Marie D; Huber F; Marty C; Couppié P
    Med Trop (Mars); 2008 Feb; 68(1):33-7. PubMed ID: 18478769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidrug therapy--the pathway for global leprosy elimination.
    al-Qubati Y; al-Kubati AS
    Indian J Lepr; 2000; 72(4):477-90. PubMed ID: 11212482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acedapsone (DADDS) treatment of leprosy patients in the Karimui of Papua New Guinea: status at six years.
    Russell DA; Shepard CC; McRae DH; Scott GC; Vincin DR
    Am J Trop Med Hyg; 1975 May; 24(3):485-95. PubMed ID: 1098496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renaissance of Hansen's Disease in Post-Elimination Era in North India: A Retrospective Clinico-Bacteriological Study.
    Hazarika N; Gupta PK; Dhanta A; Singh A; Mohanty A; Gupta P
    Cureus; 2021 Aug; 13(8):e17514. PubMed ID: 34603886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of socioeconomic condition and bacillary index with respect to the development of Hansen's disease.
    Gautam S; Sharma D; Singh S; Arora M; Goel A; Bisht D
    Int J Mycobacteriol; 2023; 12(3):254-260. PubMed ID: 37721229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relapses during long-term follow up with drug-susceptible M. leprae among multibacillary leprosy patients treated with multidrug therapy regimens; case reports.
    Thomas A; Hari L; Nagarajan M; Prabhakar R
    Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):391-4. PubMed ID: 7594922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Author's reply.
    Sengupta U
    Indian J Dermatol Venereol Leprol; 2018; 84(4):445. PubMed ID: 29893300
    [No Abstract]   [Full Text] [Related]  

  • 33. Histoid leprosy: a retrospective study of 40 cases from India.
    Kaur I; Dogra S; De D; Saikia UN
    Br J Dermatol; 2009 Feb; 160(2):305-10. PubMed ID: 19016704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two microbiological relapses in a patient with lepromatous leprosy.
    Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
    Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance to anti leprosy drugs in multi-bacillary leprosy: A cross sectional study from a tertiary care centre in eastern Uttar Pradesh, India.
    Singh SK; Kumar A; Nath G; Singh TB; Mishra MN
    Indian J Dermatol Venereol Leprol; 2018; 84(3):275-279. PubMed ID: 29536982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of relapse in multibacillary leprosy.
    Jakeman P
    Lancet; 1995 Jan; 345(8941):4-5. PubMed ID: 7799708
    [No Abstract]   [Full Text] [Related]  

  • 37. Primary dapsone resistant Mycobacterium leprae in a non endemic country.
    Jamil A; Noor NM; Osman AS; Baseri MM; Muthupalaniappen L
    Indian J Dermatol Venereol Leprol; 2013; 79(4):527-9. PubMed ID: 23760326
    [No Abstract]   [Full Text] [Related]  

  • 38. Epidemiological trends of leprosy elimination in CLTRI rural field operation area, Tamil Nadu, India.
    Subramanian M; Thorat DM; Krishnan CB; Baig AA; Prabakaran I; Hassan TF; Oommen PK
    Indian J Lepr; 2006; 78(2):203-14. PubMed ID: 16927854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leprosy trend in Agra: observations from data collected from a hospital and field.
    Kumar A; Yadav VS; Chakma JK; Girdhar A; Girdhar BK
    Indian J Lepr; 2006; 78(2):195-202. PubMed ID: 16927853
    [No Abstract]   [Full Text] [Related]  

  • 40. Leprosy in Iran: an analysis of 195 cases from 1994-2009.
    Golfurushan F; Sadeghi M; Goldust M; Yosefi N
    J Pak Med Assoc; 2011 Jun; 61(6):558-61. PubMed ID: 22204210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.